Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-38.46%
0%
-38.46%
6 Months
-38.46%
0%
-38.46%
1 Year
-37.5%
0%
-37.5%
2 Years
-24.53%
0%
-24.53%
3 Years
-41.18%
0%
-41.18%
4 Years
-92.45%
0%
-92.45%
5 Years
-96.26%
0%
-96.26%
Cambridge Nutritional Sciences Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-1.10%
EBIT Growth (5y)
8.93%
EBIT to Interest (avg)
-1.05
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.47
Sales to Capital Employed (avg)
0.72
Tax Ratio
41.70%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.14%
ROE (avg)
2.47%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.60
EV to EBIT
-2.26
EV to EBITDA
-2.26
EV to Capital Employed
0.33
EV to Sales
0.27
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-9.98%
ROE (Latest)
-2.32%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Mar'23
Mar'23
Mar'22
Change(%)
Net Sales
7.50
8.50
-11.76%
Operating Profit (PBDIT) excl Other Income
-2.20
-0.00
Interest
0.00
0.00
Exceptional Items
-0.50
-0.30
-66.67%
Consolidate Net Profit
-3.20
-1.40
-128.57%
Operating Profit Margin (Excl OI)
-368.30%
-68.20%
-30.01%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2023 is -11.76% vs 25.00% in Mar 2022
Consolidated Net Profit
YoY Growth in year ended Mar 2023 is -128.57% vs -450.00% in Mar 2022
About Cambridge Nutritional Sciences Plc 
Cambridge Nutritional Sciences Plc
Pharmaceuticals & Biotechnology
Omega Diagnostics Group PLC is a medical diagnostics company. The Company's segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers. For allergy, it offers Allergodip, which is an enzyme immunoassay for the semi-quantitative determination of Specific immunoglobulin E (IgE) in serum or plasma. For anemia, it offers ATHOZYME Ferritin, which is an enzyme-immunoassay (ELISA) test for the detection and quantification of Ferritin in human serum. It offers a range of products for Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Antiphospholipid Syndrome (APS), Connective Tissue Disease, Gastrointestinal, and Vasculitis and Renal Disease. Its Fertility Hormones products include PATHOZYME-LH (Luteinizing Hormone), PATHOZYME-Prolactin and PATHOZYME-Oestradiol.
Company Coordinates 
Company Details
Omega House, Hillfoots Business Village, Scotland ALVA None : FK12 5DQ
Registrar Details






